Practice Management News

Gastroenterology had a big year in 2022, with potentially game-changing FDA approvals for inflammatory bowel disease and several first-in-class therapies, yet the FDA’s rejection of the first hepatitis D therapy still looms large.

The Residency to Retirement resource center offers insightful and innovative strategies to help physicians reduce taxes, protect assets, invest wisely and build wealth during all phases of their careers.

In this video exclusive, Austin L. Chiang, MD, MPH, named a 2022 Disruptive Innovator for his impact on social media, discusses how health care professionals — specifically gastroenterologists — can successfully use this form of outreach.

AbbVie announced that it has submitted a supplemental new drug application for Linzess for the treatment of functional constipation in patients aged 6 to 17 years, according to a press release.

Routine use of over-the-scope clip as primary hemostasis did not decrease 30-day rebleeding compared with conventional therapy in patients with bleeding peptic ulcers at least 15 mm in size, according to research published in Gut.

Through the end of September, the S&P 500 had declined three consecutive quarters and lost nearly 24% of its value.

Disorders of gut-brain interaction cause symptoms throughout the digestive tract including pain, changes in bowel patterns, nausea, regurgitation or vomiting, which can be upsetting or embarrassing for children and teens

Results from a meta-analysis underscored the need to improve understanding of nonalcoholic fatty liver disease burden and management in at-risk individuals who are overweight and obese.

Surgeries performed by female gastrointestinal surgeons in Japan have no significant differences in outcomes compared with those conducted by their male counterparts, according to a study published in The BMJ.

ASGE announced a new collaboration with Surgical Science to develop gastrointestinal endoscopy simulation-based training and curricula.